Aurora Kinase Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments
Download the sample report @ https://www.pharmaproff.com/request-sample/1174
Several studies have demonstrated overexpression and amplification of aurora kinase in various haematological and solid cancers. Aurora kinase inhibitors when combined with other anti-cancer agents gives more positive results in variety of cancers. Better evaluation of aurora kinase inhibitors is required which raises the need of biomarkers, effective and novel therapeutic agents. Also, aurora kinase inhibitors selectivity targets cancer cells rather than healthy tissues, providing potential opportunities for more effective drug development with reduced adverse effects.
Get the detailed analysis @ https://www.pharmaproff.com/report/aurora-kinase-inhibitor-therapeutics
AstraZeneca PLC is in the process of developing AZD-2811 as a small molecule which acts as an aurora B inhibitor for the treatment of solid tumors. Some of the other companies having pipeline of aurora kinase inhibitors include AbbVie Inc., Merck & Co., Inc., and CASI Pharmaceuticals Inc.
Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1174
The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licencing, grants, technology and others.
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aurora Kinase Inhibitor Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments here
News-ID: 1683625 • Views: 343
More Releases from Pharma Proff
Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates. IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates. Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Pate …
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome. Download the sample report at: https://www.pharmaproff.com/request-sample/1189 Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances
More Releases for Aurora
Cannabis Infused Products Market Worth Observing Growth|Canopy Growth, Aurora Ca …
Cannabis Infused Products Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to witness the growth at an annual pace of 22.0% in the forecast period. The growing awareness about the well-being and mental health benefits is driving the market scope of cannabis infused products. Cannabis infused products market is growing with the successive application of marijuana or
Aurora Kinase A Global Market Research Report 2025
Aurora Kinase A Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/aurora-kinase-a-market/80983 The report firstly introduced the Aurora Kinase A basics: definitions, classifications, applications
Aurora Kinase Inhibitor Global Market Research Report 2025
Aurora Kinase Inhibitor Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/aurora-kinase-inhibitor-market/80982 The report firstly introduced the Aurora Kinase Inhibitor basics: definitions, classifications, applications
Global Shredders Market 2018 - Ativa, Aurora Corp., Fellowes, GoECOlife
Apex Market Reports, recently published a detailed market research study focused on the “Shredders Market” across the global, regional and country level. The report provides 360° analysis of “Shredders Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Shredders on the basis of
Global Automotive Fuse Market 2018 - Aurora, Conquer, Hansor, Zhenhui
Global Automotive Fuse Market 2018 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Automotive Fuse piece of the overall industry and Growth patterns, concentrating on driving Automotive Fuse industry players, showcase size, request and supply examination, utilization volume, Forecast 2017 to 2025. The major regions present in the continents like United States, Germany, Japan and China and their contribution to global Automotive Fuse market is
Aurora Kinase A (Aurora 2 or SerineThreonine Protein Kinase 15 or SerineThreonin …
ReportsWorldwide has announced the addition of a new report title Aurora Kinase A (Aurora 2 or SerineThreonine Protein Kinase 15 or SerineThreonine Protein Kinase 6 or SerineThreonine Protein Kinase Aurora A or AuroraIPL1 Related Kinase 1 or AURKA or EC 184.108.40.206) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary According to the recently published report 'Aurora Kinase A - Pipeline Review, H2 2017'; Aurora Kinase